These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1079920)

  • 1. Inhibition of the biosynthesis of 5'-phosphoribosyl-N-formylglycinamide in sarcoma 180 cells by homofolate.
    Divekar AY; Hakala MT
    Mol Pharmacol; 1975 May; 11(3):319-25. PubMed ID: 1079920
    [No Abstract]   [Full Text] [Related]  

  • 2. Homofolate and tetrahydrohomofolate, inhibitors of purine synthesis.
    Hakala MT
    Cancer Res; 1971 Jun; 31(6):813-6. PubMed ID: 5314462
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic blocks and unique features in the biosynthesis of 5'-phosphoribosyl-N-formylglycinamide in Salmonella typhimurium.
    Westby CA; Gots JS
    J Biol Chem; 1969 Apr; 244(8):2095-102. PubMed ID: 4889464
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of purine biosynthesis de novo in sarcoma 180 ascites cells by mercapto and seleno purine analogs.
    Crabtree GW; Scholar EM; Chu SH; Parks RE
    Biochem Pharmacol; 1973 Jan; 22(2):155-62. PubMed ID: 4357793
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of ammonia utilization for purine biosynthesis by the intact cell and characterization of the enzymatic activity catalyzing this reaction.
    King G; Meade JC; Bounous CG; Holmes EW
    Metabolism; 1979 Apr; 28(4):348-57. PubMed ID: 449688
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of HKSV28 cell growth by 5,11-methenyl-tetrahydrohomofolate.
    Slieker LJ; Benkovic SJ
    Mol Pharmacol; 1984 Mar; 25(2):294-302. PubMed ID: 6700575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of serine metabolism by tetrahydrohomofolate in L1210 mouse leukemia cells.
    Scanlon KJ; Cashmore AR; Moroson BA; Dreyer RN; Bertino JR
    Mol Pharmacol; 1981 May; 19(3):481-90. PubMed ID: 6790934
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of purine ribonucleotide and phosphoribosyl pyrophosphate synthesis by 6-cyclopentylthio-9-hydroxymethylpurine and structurally related compounds.
    Smith CM; Fontenelle LJ; Lalanne M; Henderson JF
    Cancer Res; 1974 Mar; 34(3):463-7. PubMed ID: 4359876
    [No Abstract]   [Full Text] [Related]  

  • 9. De novo purine biosynthesis by two pathways in Burkitt lymphoma cells and in human spleen.
    Reem GH
    J Clin Invest; 1972 May; 51(5):1058-62. PubMed ID: 5020428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-(delta2-isopentenyl)adenosine 5'-monophosphate: formation and effect on purine metabolism in cellular and enzymatic systems.
    Divekar AY; Slocum HK; Hakala MT
    Mol Pharmacol; 1974 May; 10(3):529-43. PubMed ID: 4368972
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of 5-phosphoribosyl-1-pyrophosphate (PRPP) synthesis in human fibroblasts.
    Raivio KO; Lazar C; Krumholz H; Becker MA
    Adv Exp Med Biol; 1979; 122B():31-4. PubMed ID: 94761
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of methotrexate polyglutamate accumulation in cultured human cells.
    Rosenblatt DS; Whitehead VM; Vuchich MJ; Pottier A; Matiaszuk NV; Beaulieu D
    Mol Pharmacol; 1981 Jan; 19(1):87-91. PubMed ID: 6163074
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of combination of folic acid and anticancer drugs on the growth of sarcoma 180 in mice.
    Indap MA; Gokhale SV
    J Postgrad Med; 1984 Jan; 30(1):23-6. PubMed ID: 6716305
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid.
    Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB
    Mutat Res; 2009 Feb; 673(1):43-52. PubMed ID: 19110071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycinamide ribonucleotide formyltransferase and other folate enzymes by homofolate polyglutamates in human lymphoma and murine leukemia cell extracts.
    Thorndike J; Gaumont Y; Kisliuk RL; Sirotnak FM; Murthy BR; Nair MG; Piper JR
    Cancer Res; 1989 Jan; 49(1):158-63. PubMed ID: 2521177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dimethyl sulphoxide on glycine transport in sarcoma 180 tumour cells.
    Hagemann RF; Evans TC
    Nature; 1968 May; 218(5141):583-4. PubMed ID: 5655188
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of glycine-serine interconversion in cultured human fibroblasts by products of isoleucine catabolism.
    Hillman RE; Otto EF
    Pediatr Res; 1974 Dec; 8(12):941-5. PubMed ID: 4444863
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspects of the biochemical pharmacology of cytembena.
    Jackson RC; Taylor GA; Harrap KR
    Neoplasma; 1975; 22(3):259-68. PubMed ID: 1080553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of treatment with cytotoxic agents on mouse spleen dihydrofolate reductase activity.
    Canellos GP; Mead JA; Greenberg NH; Schrecker AW
    Cancer Res; 1967 Apr; 27(4):784-8. PubMed ID: 4225918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.